Table 4. Multivariate analysis.
GPS-NLR model | ALI model | |||||
---|---|---|---|---|---|---|
p value | HR | 95% CI | p value | HR | 95% CI | |
Gender (male/female) | 0.007 | 0.27 | 0.1–0.7 | 0.002 | 0.22 | 0.09–0.58 |
CEA, ng/mL (≤5/>5) | 0.109 | 2.23 | 0.84–5.93 | 0.235 | 1.8 | 0.68–4.72 |
GPS (0/1-2) | 0.754 | 1.24 | 0.32–4.77 | |||
RDW (<13.3/≥13.3) | 0.012 | 3.11 | 1.28–7.55 | 0.023 | 2.78 | 1.15–6.69 |
NLR (<3.43/≥3.43) | 0.011 | 3.91 | 1.36–11.26 | |||
ALI (≥22.2/<22.2) | <0.001 | 7.55 | 3.03–18.8 |
CEA: carcinoembryonic antigen; GPS: Glasgow prognostic score; RDW: red cell distribution width; NLR: neutrophil-to-lymphocyte ratio; ALI: advanced lung cancer inflammation index; HR: hazard ratio; CI: confidence interval